148 related articles for article (PubMed ID: 37434022)
1. [Legal aspects of telemedicine in cardiology in Germany].
Wenzelburger FWG; Schumacher B
Herzschrittmacherther Elektrophysiol; 2023 Sep; 34(3):193-197. PubMed ID: 37434022
[TBL] [Abstract][Full Text] [Related]
2. Implant-based multi-parameter telemonitoring of patients with heart failure and a defibrillator with vs. without cardiac resynchronization therapy option: a subanalysis of the IN-TIME trial.
Geller JC; Lewalter T; Bruun NE; Taborsky M; Bode F; Nielsen JC; Stellbrink C; Schön S; Mühling H; Oswald H; Reif S; Kääb S; Illes P; Proff J; Dagres N; Hindricks G;
Clin Res Cardiol; 2019 Oct; 108(10):1117-1127. PubMed ID: 30874886
[TBL] [Abstract][Full Text] [Related]
3. [Telemedicine for patients with cardiac implants : Insights into everyday practice of remote monitoring in Germany in 2022].
Steiner B; Zippel-Schultz B; Thoden E; Geller CJ; Klingenheben T; Kröttinger A; Leonhardt VG; Placke J; Helms TM
Herzschrittmacherther Elektrophysiol; 2024 Jun; 35(2):132-139. PubMed ID: 38789580
[TBL] [Abstract][Full Text] [Related]
4. Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management.
Chia PL; Foo D
Singapore Med J; 2016 Jul; 57(7):354-9. PubMed ID: 27440409
[TBL] [Abstract][Full Text] [Related]
5. Risk of Ventricular Tachyarrhythmic Events in Patients Who Improved Beyond Guidelines for a Defibrillator in MADIT-CRT.
Sherazi S; Shah F; Kutyifa V; McNitt S; Aktas MK; Polonsky B; Zareba W; Goldenberg I
JACC Clin Electrophysiol; 2019 Oct; 5(10):1172-1181. PubMed ID: 31648742
[TBL] [Abstract][Full Text] [Related]
6. The mortality analysis of primary prevention patients receiving a cardiac resynchronization defibrillator (CRT-D) or implantable cardioverter-defibrillator (ICD) according to guideline indications in the improve SCA study.
Ching CK; Hsieh YC; Liu YB; Rodriguez DA; Kim YH; Joung B; Singh B; Huang D; Hussin A; Chasnoits AR; O'Brien JE; Cerkvenik J; Lexcen D; Van Dorn B; Zhang S
J Cardiovasc Electrophysiol; 2021 Aug; 32(8):2285-2294. PubMed ID: 34216069
[TBL] [Abstract][Full Text] [Related]
7. Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT Survey II.
Lawin D; Israel CW; Linde C; Normand C; Dickstein K; Lober C; Gitt AK; Hindricks G; Stellbrink C;
Clin Res Cardiol; 2020 Jul; 109(7):832-844. PubMed ID: 31811440
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of telemedicine devices in patients with severe heart failure with an implanted cardiac resynchronization therapy system during two years of observation.
Wita M; Orszulak M; Szydło K; Wróbel W; Filipecki A; Simionescu K; Sanecki K; Uchwat U; Wybraniec M; Tabor Z; Gołba K; Wita K; Mizia-Stec K
Kardiol Pol; 2022; 80(1):41-48. PubMed ID: 34883524
[TBL] [Abstract][Full Text] [Related]
9. [Telemonitoring of implantable devices. Practical aspects and ongoing studies].
Bosch RF; Krause-Allmendinger H; Villena P; Kruck I
Herzschrittmacherther Elektrophysiol; 2009 Dec; 20(4):179-84. PubMed ID: 19941146
[TBL] [Abstract][Full Text] [Related]
10. Implantable cardioverter defibrillators and cardiac resynchronisation therapy.
Holzmeister J; Leclercq C
Lancet; 2011 Aug; 378(9792):722-30. PubMed ID: 21856486
[TBL] [Abstract][Full Text] [Related]
11. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
[TBL] [Abstract][Full Text] [Related]
12. Is 24/7 remote patient management in heart failure necessary? Results of the telemedical emergency service used in the TIM-HF and in the TIM-HF2 trials.
Winkler S; Koehler K; Prescher S; Koehler M; Kirwan BA; Tajsic M; Koehler F
ESC Heart Fail; 2021 Oct; 8(5):3613-3620. PubMed ID: 34182596
[TBL] [Abstract][Full Text] [Related]
13. Day by day telemetric care of patients treated with cardiac resynchronisation therapy: first Polish experience.
Liberska A; Kowalski O; Mazurek M; Lenarczyk R; Jędrzejczyk-Patej E; Przybylska-Siedlecka K; Kozieł M; Morawski S; Podolecki T; Kowalczyk J; Pruszkowska P; Pluta S; Sokal A; Kalarus Z
Kardiol Pol; 2016; 74(8):741-748. PubMed ID: 26898970
[TBL] [Abstract][Full Text] [Related]
14. CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how?
Dickstein K; Normand C; Auricchio A; Bogale N; Cleland JG; Gitt AK; Stellbrink C; Anker SD; Filippatos G; Gasparini M; Hindricks G; Blomström Lundqvist C; Ponikowski P; Ruschitzka F; Botto GL; Bulava A; Duray G; Israel C; Leclercq C; Margitfalvi P; Cano Ó; Plummer C; Sarigul NU; Sterlinski M; Linde C
Eur J Heart Fail; 2018 Jun; 20(6):1039-1051. PubMed ID: 29457358
[TBL] [Abstract][Full Text] [Related]
15. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
[TBL] [Abstract][Full Text] [Related]
16. Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC).
Mullens W; Dauw J; Gustafsson F; Mebazaa A; Steffel J; Witte KK; Delgado V; Linde C; Vernooy K; Anker SD; Chioncel O; Milicic D; Hasenfuß G; Ponikowski P; von Bardeleben RS; Koehler F; Ruschitzka F; Damman K; Schwammenthal E; Testani JM; Zannad F; Böhm M; Cowie MR; Dickstein K; Jaarsma T; Filippatos G; Volterrani M; Thum T; Adamopoulos S; Cohen-Solal A; Moura B; Rakisheva A; Ristic A; Bayes-Genis A; Van Linthout S; Tocchetti CG; Savarese G; Skouri H; Adamo M; Amir O; Yilmaz MB; Simpson M; Tokmakova M; González A; Piepoli M; Seferovic P; Metra M; Coats AJS; Rosano GMC
Eur J Heart Fail; 2024 Feb; 26(2):483-501. PubMed ID: 38269474
[TBL] [Abstract][Full Text] [Related]
17. Awareness of indications for device therapy among a broad range of physicians: a survey study.
Hübinette C; Lund LH; Gadler F; Ståhlberg M
Europace; 2014 Nov; 16(11):1580-6. PubMed ID: 24451291
[TBL] [Abstract][Full Text] [Related]
18. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
[TBL] [Abstract][Full Text] [Related]
19. Adherence to ESC cardiac resynchronization therapy guidelines: findings from the ESC CRT Survey II.
Normand C; Linde C; Blomström-Lundqvist C; Stellbrink C; Gasparini M; Anker SD; Plummer C; Sarigul NU; Papiashvili G; Iovev S; Dickstein K
Europace; 2020 Jun; 22(6):932-938. PubMed ID: 32330937
[TBL] [Abstract][Full Text] [Related]
20. [Telemedicine in cardiology - what is new?].
Schneider D; Köhler K; Köhler F
Dtsch Med Wochenschr; 2023 Jun; 148(12):767-773. PubMed ID: 37257479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
